Urolithin/mitophagy mechanism is an active and promising research area but is preclinical/early human-trial stage generally, and no finished-product trial exists for R2 Day or Nu Biome specifically, where the dose is part of an undisclosed proprietary blend. Structure/function only.
How it works
Transform — gut bacteria convert ellagitannins into urolithins, which are studied for supporting mitochondrial biogenesis and quality control
Maintain — antioxidant and anti-inflammatory polyphenol activity in vascular and gut tissue
Adapt — urolithin-driven mitophagy is a cellular stress-adaptation/cleanup pathway under active mechanistic research
Exchange — punicalagins and other ellagitannins are poorly absorbed intact -- the gut microbiome does the real metabolic work, converting them stepwise to urolithin A, the bioactive circulating metabolite, which is why individual response varies with a person's specific gut bacterial profile (people are classified into urolithin metabotypes A, B, or null)
Maintain — independent of the urolithin pathway, pomegranate polyphenols are studied for supporting endothelial nitric oxide availability and normal blood flow in small human trials
Form matters
The same nutrient can be made in very different forms — and a study done on one form does not automatically apply to another. Methylcobalamin is not cyanocobalamin; magnesium glycinate is not magnesium oxide; a whole-food extract is not the synthetic isolate that was studied. Two things decide whether what is in the bottle behaves like the research: the exact form, and independent lab verification (a Certificate of Analysis) that the form and dose on the label are truly what is inside. Without a COA, you are trusting a label, not the science.
The science on Pomegranate extract
Powered by CellWell.lifeBalanced by design — we show supporting and contradicting findings. Search all studies